Microbial Engineering/Alternative Host Bioprocessing Intern - Onsite, Marlborough, MA
Sartorius
Summary
The internship program at Alternative Host Bioprocessing unit at Sartorius Stedim North America, Corporate Research Labs, Marlborough MA focuses on Microbial strain engineering. We are seeking a motivated and detail-oriented Research Intern to join our group. This role offers an exciting opportunity to work under the supervision of the Principal Investigator on cutting-edge research in microbiology, molecular biology, and biotechnology.
Job description
Grow with Us - Your Responsibilities
- Conduct laboratory experiments under the supervision and guidance of the Principal Investigator (PI).
- Maintain microbial cultures; prepare media, buffers, and reagents; and support the day-to-day operations of the laboratory.
- Assist with molecular cloning techniques, including PCR, DNA extraction and purification, plasmid preparation, DNA assembly, and gel electrophoresis.
- Perform microbial transformation, clone screening, and preliminary assessment of strain productivity.
- Evaluate microbial growth, target molecule expression, and product yield using appropriate analytical methods.
- Follow established laboratory procedures and safety protocols while maintaining a clean, organized, and compliant laboratory environment.
- Maintain accurate and detailed records of experimental procedures, observations, and results; prepare technical reports; and present findings to the research team.
What Will Convince Us
- Currently pursuing Masters/ PhD degree in Microbiology, Molecular Biology, Chemical/Biological Engineering, Chemistry, Biochemistry, or a related field.
- Hands on experience with sterile microbial culture techniques- particularly handling bacteria, yeast, and filamentous fungi, is preferred; and molecular biology techniques is a plus.
- Hands on experience doing small scale fermentation screening, protein assays, running HPLC/ LC/MS would be a plus.
- Strong communication and interpersonal skills, hardworking, systematic, sensible, and adaptable attitude.
- Identification with our core values: Sustainability, Openness, Enjoyment
Requirements
- Currently pursuing Masters/ PhD degree in Microbiology, Molecular Biology, Chemical/Biological Engineering, Chemistry, Biochemistry, or a related field
- Hands on experience with sterile microbial culture techniques (bacteria, yeast, filamentous fungi) preferred
- Molecular biology techniques experience is a plus
- Hands on experience with small scale fermentation screening, protein assays, HPLC/LC-MS is a plus
- Strong communication and interpersonal skills
- Hardworking, systematic, sensible, and adaptable attitude
Benefits
- Welcoming Culture
- Team Support
- Team Spirit
- International Collaboration
- Coaching Community
- Agile Working Community
- Businesswomen's Network
- Modern Buildings
- Latest Technology And Equipment
Company overview
Sartorius AG is a leading international partner for life sciences research and the biopharmaceutical industry, headquartered in Göttingen, Germany. Founded in 1870, the company operates through two main divisions: Lab Products & Services and Bioprocess Solutions. The Lab Products & Services division provides innovative laboratory instruments, consumables, and bioanalytics solutions for pharmaceutical, biopharmaceutical, and academic research laboratories, holding market leadership positions in laboratory balances, pipettes, and lab consumables. The Bioprocess Solutions division offers a comprehensive portfolio of single-use technologies covering all steps in biopharmaceutical production, including filtration, fermentation, cell cultivation, and fluid management systems. With over 13,500 employees across more than 60 locations worldwide, Sartorius generated approximately €3.4 billion in sales revenue in 2024. The company serves pharmaceutical and biotechnology companies, academic research facilities, and quality control laboratories, helping accelerate drug discovery and manufacturing processes while maintaining a strong focus on innovation through strategic acquisitions of complementary technologies.